Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aurinia Pharmaceuticals Raises FY2025 Sales Guidance from $250.00M-$260.00M to $260.00M-$270.00M vs $258.52M Est

Author: Benzinga Newsdesk | July 31, 2025 05:01am
Aurinia Pharmaceuticals (NASDAQ:AUPH) raises FY2025 sales outlook from $250.00 million-$260.00 million to $260.00 million-$270.00 million vs $258.52 million estimate.

Posted In: AUPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist